Evidence map›Paper›PMID 36510242›Full record

ArticleTrials2022

Considerations when introducing electronic patient-reported outcome data capture in multicentre oncology randomised controlled trials.

Lara Philipps, Stephanie Foster, Deborah Gardiner, Alexa Gillman, Joanne Haviland, Elizabeth Hill, Georgina Manning, Morgaine Stiles, Emma Hall, Rebecca Lewis

Abstract readMulticenter StudyLetter
In one paragraph

Article in Trials, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Lara PhilippsClinical Trials and Statistics Unit, The Institute of Cancer Research, London, SM2 5NG, UK. Lara.philipps@icr.ac.uk.ORCID 0000-0002-3736-9798
Stephanie FosterClinical Trials and Statistics Unit, The Institute of Cancer Research, London, SM2 5NG, UK.
Deborah GardinerClinical Trials and Statistics Unit, The Institute of Cancer Research, London, SM2 5NG, UK.
Alexa GillmanClinical Trials and Statistics Unit, The Institute of Cancer Research, London, SM2 5NG, UK.
Joanne HavilandClinical Trials and Statistics Unit, The Institute of Cancer Research, London, SM2 5NG, UK.
Elizabeth HillClinical Trials and Statistics Unit, The Institute of Cancer Research, London, SM2 5NG, UK.
Georgina ManningClinical Trials and Statistics Unit, The Institute of Cancer Research, London, SM2 5NG, UK.
Morgaine StilesClinical Trials and Statistics Unit, The Institute of Cancer Research, London, SM2 5NG, UK.
Emma HallClinical Trials and Statistics Unit, The Institute of Cancer Research, London, SM2 5NG, UK.
Rebecca LewisClinical Trials and Statistics Unit, The Institute of Cancer Research, London, SM2 5NG, UK.

Funding

Cancer Research UK 30384Cancer Research UK A30384Cancer Research UK C1491/A25351
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Medical OncologyResearch DesignHumansPatient Reported Outcome MeasuresPatient SelectionRandomized Controlled Trials as TopicSoftware

Identifiers

PMID36510242
PMCPMC9744038

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.